Maxillofacial Plastic and Reconstructive Surgery

  • Volume 38
  • /
  • Pages.33.1-33.6
  • /
  • 2016
  • /
  • 2288-8101(pISSN)
  • /
  • 2288-8586(eISSN)
Korean Association of Maxillofacial Plastic and Reconstructive Surgeons (대한악안면성형재건외과학회)
권호 표지
DOI QR코드

DOI QR Code

S100 and p65 expression are increased in the masseter muscle after botulinum toxin-A injection

  • Park, Young-Wook (Department of Oral and Maxillofacial Surgery, College of Dentistry, Gangneung-Wonju National University) ;
  • Kim, Seong-Gon (Department of Oral and Maxillofacial Surgery, College of Dentistry, Gangneung-Wonju National University) ;
  • Jo, You-Young (Sericultural and Apicultural Materials Division, National Academy of Agricultural Science)
  • Received : 2016.07.04
  • Accepted : 2016.08.22
  • Published : 2016.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: The purpose of this study was to compare the expression levels of p65 and S100 in the rat masseter muscle after the injection of different concentrations of botulinum toxin-A (BTX-A). Methods: We injected either 5 or 10 U of BTX-A into both masseter muscle of rats. As a control group, the same volume of saline was injected. After 14 days, the animals were sacrificed. Subsequently, a biopsy and immunohistochemical staining of the samples were performed using a p65 or S100 antibody. Results: The cross-sectional area of each myofibril was significantly reduced by BTX-A injection (P < 0.001). The expression of p65 and S100 increased significantly with increasing concentrations of BTX-A (P < 0.001). Conclusions: The injection of BTX-A into the masseter muscle induced muscle atrophy. Subsequently, p65 and S100 expression in myoblasts were increased for the protection of muscle cells.

Keywords

References

  1. Burgen A, Dickens F, Zatman L (1949) The action of botulinum toxin on the neuro-muscular junction. J Physiol 109:10-23 https://doi.org/10.1113/jphysiol.1949.sp004364
  2. Schiavo G, Benfenati F, Poulain B, Rossetto O, Polverino de Laureto P, DasGupta BR et al (1992) Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 359:832-835 https://doi.org/10.1038/359832a0
  3. Su JZ, Cai ZG, Yu GY (2015) Microvascular autologous submandibular gland transplantation in severe cases of keratoconjunctivitis sicca. Maxillofac Plast Reconstr Surg 37:5 https://doi.org/10.1186/s40902-015-0006-4
  4. Navarrete AL, Rafferty KL, Liu ZJ, Ye W, Greenlee GM, Herring SW (2013) Botulinum neurotoxin type A in the masseter muscle: effects on incisor eruption in rabbits. Am J Orthod Dentofacial Orthop 143:499-506 https://doi.org/10.1016/j.ajodo.2012.10.023
  5. Park SY, Park YW, Ji YJ, Park SW, Kim SG (2015) Effects of a botulinum toxin type A injection on the masseter muscle: an animal model study. Maxillofac Plast Reconstr Surg 37:10 https://doi.org/10.1186/s40902-015-0010-8
  6. Seok H, Lee SW, Kim MK, Kim SG, Park YW, Park SW et al (2013) Correction of post-traumatic lower lip asymmetry using botulinum toxin type A. J Korean Assoc Maxillofac Plast Reconstr Surg 35:256-259
  7. Ansved T, Odergren T, Borg K (1997) Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia. Neurology 48:1440-1442 https://doi.org/10.1212/WNL.48.5.1440
  8. Kun-Darbois J-D, Libouban H, Chappard D (2015) Botulinum toxin in masticatory muscles of the adult rat induces bone loss at the condyle and alveolar regions of the mandible associated with a bone proliferation at a muscle enthesis. Bone 77:75-82 https://doi.org/10.1016/j.bone.2015.03.023
  9. Tsai CY, Lei YY, Yang LY, Chiu WC (2015) Changes of masseter muscle activity following injection of botulinum toxin type A in adult rats. Orthod Craniofac Res 18:202-211 https://doi.org/10.1111/ocr.12095
  10. Blitzer A, Brin MF, Greene PE, Fahn S (1989) Botulinum toxin injection for the treatment of oromandibular dystonia. Ann Otol Rhinol Laryngol 98:93-97 https://doi.org/10.1177/000348948909800202
  11. Kim HS, Yun PY, Kim YK (2016) A clinical evaluation of botulinum toxin-A injections in the temporomandibular disorder treatment. Maxillofac Plast Reconstr Surg 38:5 https://doi.org/10.1186/s40902-016-0051-7
  12. von Lindern JJ, Niederhagen B, Appel T, Berge S, Reich RH (2001) Type A botulinum toxin for the treatment of hypertrophy of the masseter and temporal muscles: an alternative treatment. Plast Reconstr Surg 107:327-332 https://doi.org/10.1097/00006534-200102000-00004
  13. Duchen L, Strich SJ (1968) The effects of botulinum toxin on the pattern of innervation of skeletal muscle in the mouse. Q J Exp Physiol Cogn Med Sci 53:84-89
  14. Arora R, Yates C, Gary BD, McClellan S, Tan M, Xi Y et al (2014) Panepoxydone targets NF-kB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancer. PLoS One 9(6):e98370 https://doi.org/10.1371/journal.pone.0098370
  15. Warden SJ, Galley MR, Richard JS, George LA, Guildenbecher EA, Judd AM et al (2013) Reduced gravitational loading does not account for the skeletal effect of botulinum toxin-induced muscle inhibition suggesting a direct effect of muscle on bone. Bone 54:98-105 https://doi.org/10.1016/j.bone.2013.01.043
  16. von Lindern JJ, Niederhagen B, Berge S, Appel T (2003) Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity. J Oral Maxillofac Surg 61:774-778 https://doi.org/10.1016/S0278-2391(03)00153-8
  17. Moon YM, Kim YJ, Kim MK, Kim SG, Kweon HY, Kim TW (2015) Early effect of Botox-A injection into the masseter muscle of rats: functional and histological evaluation. Maxillofac Plast Reconstr Surg 37:46 https://doi.org/10.1186/s40902-015-0049-6
  18. Ilg EC, Schafer BW, Heizmann CW (1996) Expression pattern of S100 calcium-binding proteins in human tumors. Int J Cancer 68:325-332 https://doi.org/10.1002/(SICI)1097-0215(19961104)68:3<325::AID-IJC10>3.0.CO;2-7
  19. Mischke D, Korge BP, Marenholz I, Volz A, Zieqler A (1996) Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex ("epidermal differentiation complex") on human chromosome 1q21. J Invest Dermatol 106:989-992 https://doi.org/10.1111/1523-1747.ep12338501
  20. Heatwole VM (1999) TUNEL assay for apoptotic cells. Immunocytochemical Methods and Protocols. Springer, Heidelberg, p 141-148
  21. Wu SH, Huang SH, Cheng KI, Chai CY, Yeh JL et al (2015) Third-degree hindpaw burn injury induced apoptosis of lumbar spinal cord ventral horn motor neurons and sciatic nerve and muscle atrophy in rats. BioMed Res Int 2015:372819
  22. Magnusson-Lind A, Davidsson M, Silajdzic E, Hansen C, McCourt AC, Tabrizi SJ et al (2014) Skeletal muscle atrophy in r6/2 mice-altered circulating skeletal muscle markers and gene expression profile changes. J Huntingtons Dis 3:13-24
  23. Kim HC, Song JM, Kim CJ, Yoon SY, Kim IR, Park BS et al (2015) Combined effect of bisphosphonate and recombinant human bone morphogenetic protein 2 on bone healing of rat calvarial defects. Maxillofac Plast Reconstr Surg 37:16 https://doi.org/10.1186/s40902-015-0015-3
  24. Vegger JB, Bruel A, Thomsen JS (2015) Vertical trabeculae are thinned more than horizontal trabeculae in skeletal-unloaded rats. Calcif Tissue Int 97:516-526 https://doi.org/10.1007/s00223-015-0035-0
  25. Yamaki T, Wu CL, Gustin M, Lim J, Jackman RW, Kandarian SC (2012) Rel A/p65 is required for cytokine-induced myotube atrophy. Am J PhysiolCell Physiol 303:C135-C142 https://doi.org/10.1152/ajpcell.00111.2012
  26. Sorci G, Riuzzi F, Agneletti AL, Marchetti C, Donato R (2004) S100B causes apoptosis in a myoblast cell line in a RAGE-independent manner. J Cell Physiol 199:274-283 https://doi.org/10.1002/jcp.10462
  27. Seo BN, Ryu JM, Yun SP, Jeon JH, Park SS, Oh KB et al (2013) Delphinidin prevents hypoxia-induced mouse embryonic stem cell apoptosis through reduction of intracellular reactive oxygen species-mediated activation of JNK and NF-kB, and Akt inhibition. Apoptosis 18:811-824 https://doi.org/10.1007/s10495-013-0838-2
  28. Heizmann CW (2013) The calcium signal is transmitted into an intracellular response via the families of calcium-binding proteins which are thought to be involved in the regulation of many cellular activities. Calcium Transport and Intracellular Calcium Homeostasis, vol 48. NATO Advanced Research Workshop, Lyon, p 301
  29. Mishra SK, Siddique HR, Saleem M (2012) S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence. Cancer Metastasis Rev 31:163-172 https://doi.org/10.1007/s10555-011-9338-4
  30. Yu SP, Canzoniero LM, Choi DW (2001) Ion homeostasis and apoptosis. Curr Opin Cell Biol 13:405-411 https://doi.org/10.1016/S0955-0674(00)00228-3
  31. Riuzzi F, Sorci G, Donato R (2006) S100B stimulates myoblast proliferation and inhibits myoblast differentiation by independently stimulating ERK1/2 and inhibiting p38 MAPK. J Cell Physiol 207:461-470 https://doi.org/10.1002/jcp.20580
  32. Moon YM, Kim MK, Kim SG, Kim TW (2016) Apoptotic action of botulinum toxin on masseter muscle in rats: early and late changes in the expression of molecular markers. Springerplus 5:991 https://doi.org/10.1186/s40064-016-2680-9

Cited by

  1. Botulinum Toxin Conjugated With Silk Fibroin and 4-Hexylresorcinol vol.28, pp.4, 2016, https://doi.org/10.1097/scs.0000000000003763
  2. Correction of Malocclusion by Botulinum Neurotoxin Injection into Masticatory Muscles vol.10, pp.1, 2018, https://doi.org/10.3390/toxins10010027